blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1840215

EP1840215 - METHOD OF INHIBITING TELOMERASE ACTIVITY AND INHIBITOR [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  10.10.2008
Database last updated on 15.06.2024
Most recent event   Tooltip10.10.2008Application deemed to be withdrawnpublished on 12.11.2008  [2008/46]
Applicant(s)For all designated states
DAIICHI PHARMACEUTICAL CO., LTD.
14-10, Nihonbashi 3-chome Chuo-ku
Tokyo 103-8234 / JP
[2007/40]
Inventor(s)01 / WADA, Naoya c/o Daiichi Pharmaceutical Co., Ltd.
Tokyo R & D Center, 16-13, Kita-Kasai 1-chome, Edogawa-ku
Tokyo 1348630 / JP
02 / OKAMOTO, Takashi
23-7-103, Naka Kasai 3-chome, Edogawa-ku
Tokyo 1340083 / JP
03 / TANIGAKI, Keiji
6-20, Mitsugarasu 6-chome
Nara-shi, Nara 6310061 / JP
04 / DOI, Hirofumi c/o Celestar Lexico-Sciences, Inc.
Makuhari Techno Garden D17, 3, Nakase 1-chome, Mihama-ku
Chiba-shi, Chiba 2618501 / JP
05 / IMAI, Kensaku c/o Celestar Lexico-Sciences, Inc.
Makuhari Techno Garden D17, 3, Nakase 1-chome, Mihama-ku
Chiba-shi, Chiba 2618501 / JP
 [2007/40]
Representative(s)Zwicker, Jörk, et al
ZSP Patentanwälte PartG mbB
Hansastraße 32
80686 München / DE
[N/P]
Former [2007/40]Zwicker, Jörk, et al
Dr. Volker Vossius Patentanwälte-Rechtsanwälte Geibelstrasse 6
81679 München / DE
Application number, filing date05822847.927.12.2005
[2007/40]
WO2005JP23902
Priority number, dateJP2004037883428.12.2004         Original published format: JP 2004378834
[2007/40]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2006070804
Date:06.07.2006
Language:EN
[2006/27]
Type: A1 Application with search report 
No.:EP1840215
Date:03.10.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 06.07.2006 takes the place of the publication of the European patent application.
[2007/40]
Search report(s)International search report - published on:JP06.07.2006
(Supplementary) European search report - dispatched on:EP21.02.2008
ClassificationIPC:C12N15/09, A61K45/00, A61P35/00, A61P43/00, C12N9/99, C12Q1/02, C12Q1/68
[2007/40]
CPC:
C12Y207/07049 (EP,US); A61K45/06 (EP,US); A61P35/00 (EP);
A61P43/00 (EP); C12N9/1241 (EP,US); G01N33/574 (EP,US);
G01N2333/9125 (EP,US); G01N2333/916 (EP,US); G01N2500/02 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/40]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:VERFAHREN ZUR HEMMUNG DER TELOMERASE-AKTIVITÄT UND INHIBITOR[2007/40]
English:METHOD OF INHIBITING TELOMERASE ACTIVITY AND INHIBITOR[2007/40]
French:PROCEDE INHIBANT L'ACTIVITE DE LA TELOMERASE ET INHIBITEUR[2007/40]
Entry into regional phase16.07.2007Translation filed 
16.07.2007National basic fee paid 
16.07.2007Search fee paid 
16.07.2007Designation fee(s) paid 
16.07.2007Examination fee paid 
Examination procedure16.07.2007Examination requested  [2007/40]
14.09.2007Amendment by applicant (claims and/or description)
23.05.2008Application deemed to be withdrawn, date of legal effect  [2008/46]
27.06.2008Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2008/46]
Fees paidRenewal fee
20.12.2007Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO9932624  (PROSCRIPT INC [US]) [A] 1-7 * whole document esp. abstract and claims *;
 [XA]  - LEON-BLANCO MM ET AL, "Melatonin inhibits telomerase activity in the MCF-7 tumor cell line both in vivo and in vitro", J. PINEAL RES, (2003), vol. 35, pages 204 - 211, XP002466598 [X] 1-3 * whole document esp. abstract and page 209 * [A] 4-7
 [A]  - GONG L ET AL, "IDENTIFICATION OF A NOVEL ISOPEPTIDES WITH DUAL SPECIFICITY FOR UBIQUITIN-AND NEDD8-CONJUGATED PROTEINS", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM,, US, (20000512), vol. 275, no. 19, ISSN 0021-9258, pages 14212 - 14216, XP000941500 [A] 1-7 * Whole document esp. abstract *

DOI:   http://dx.doi.org/10.1074/jbc.275.19.14212
 [A]  - VONDERHEIDE ROBERT H, "Telomerase as a universal tumor-associated antigen for cancer immunotherapy", ONCOGENE, BASINGSTOKE, HANTS, GB, (20020121), vol. 21, no. 4 Review Issue 1, ISSN 0950-9232, pages 674 - 679, XP002368158 [A] 1-7 * whole document esp. abstract *

DOI:   http://dx.doi.org/10.1038/sj.onc.1205074
 [A]  - UMBRICHT CB ET AL, "Human Telomerase Reverse Transcrptase Gene Expression and the Surgical Management of Suspicious Thyroid Tumors", CLINICAL CANCER RESEARCH, (200409), vol. 10, pages 5762 - 5768, XP002466599 [A] 1-7 * whole document esp. abstract and page 5767 *

DOI:   http://dx.doi.org/10.1158/1078-0432.CCR-03-0389
International search[A]  - OGRETMEN B. ET AL., "Molecular mechanisms of ceramide-mediated telomerase inhibition in the A549 human lung adenocarcinoma cell line", J.BIOL.CHEM., (2001), vol. 276, no. 35, pages 32506 - 32514, XP002997539

DOI:   http://dx.doi.org/10.1074/jbc.M101350200
 [A]  - GONG L. ET AL., "Identification of a novel isopeptidase with dual specificity for ubiquitin- and NEDD8-conjugated proteins", J.BIOL.CHEM., (2000), vol. 275, no. 19, pages 14212 - 14216, XP000941500

DOI:   http://dx.doi.org/10.1074/jbc.275.19.14212
 [A]  - WU K. ET AL., "DEN1 is a dual function protease capable of processing the C terminus of Nedd8 and deconjugating hyper-neddylated CUL1", J.BIOL.CHEM., (2003), vol. 278, no. 31, pages 28882 - 28891, XP002997540

DOI:   http://dx.doi.org/10.1074/jbc.M302888200
 [PA]  - KIM J. H. ET AL., "Ubiquitin ligase MKRN1 modulates telomere length homeostasis through a proteolysis of hTERT", GENES DEV., (2005), vol. 19, no. 7, pages 776 - 781, XP002997541

DOI:   http://dx.doi.org/10.1101/gad.1289405
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.